{"id":62815,"date":"2026-04-10T23:32:31","date_gmt":"2026-04-10T15:32:31","guid":{"rendered":"https:\/\/flcube.com\/?p=62815"},"modified":"2026-04-10T23:32:32","modified_gmt":"2026-04-10T15:32:32","slug":"thermo-fisher-scientific-partners-with-singapores-precise-to-power-landmark-proteomics-study-precise-sg100k","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=62815","title":{"rendered":"Thermo Fisher Scientific Partners with Singapore\u2019s PRECISE to Power Landmark Proteomics Study PRECISE-SG100K"},"content":{"rendered":"\n<p><strong>Thermo Fisher Scientific Inc.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/TMO:NYSE\">NYSE: TMO<\/a>), the global life sciences leader, announced a strategic collaboration with <strong>Precision Health Research, Singapore (PRECISE)<\/strong> to accelerate the <strong>PRECISE-SG100K<\/strong> population health initiative\u2014a large-scale effort to integrate deep proteomic profiling into precision medicine. The partnership will deploy Thermo Fisher\u2019s <strong>integrated proteomics ecosystem<\/strong>, combining the <strong>Olink Proximity Extension Assay (PEA)<\/strong> platform, the <strong>Orbitrap Astral\u2122 high-resolution mass spectrometry system<\/strong>, and <strong>Seer\u2019s Proteograph\u2122 Product Suite<\/strong> to generate real-time biological insights for early disease detection and personalized intervention.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-integration-framework\">Technology Integration Framework<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Component<\/th><th>Role in PRECISE-SG100K<\/th><\/tr><\/thead><tbody><tr><td><strong>Olink PEA Platform<\/strong><\/td><td>High-sensitivity, targeted quantification of 3,000+ proteins from minimal sample volumes<\/td><\/tr><tr><td><strong>Orbitrap Astral MS<\/strong><\/td><td>Ultra-fast, high-resolution discovery proteomics with deep coverage (&gt;10,000 proteins\/sample)<\/td><\/tr><tr><td><strong>Seer Proteograph<\/strong><\/td><td>Nanoparticle-based sample prep enabling unbiased, scalable plasma proteome analysis<\/td><\/tr><tr><td><strong>Data Synthesis<\/strong><\/td><td>Unified workflow linking targeted validation with hypothesis-free discovery<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>This multi-modal approach allows researchers to simultaneously conduct <strong>deep exploratory proteomics<\/strong> and <strong>high-throughput clinical-grade protein monitoring<\/strong>\u2014a critical capability for identifying early biomarkers of chronic and infectious diseases in diverse Asian populations.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-objectives-of-precise-sg100k\">Strategic Objectives of PRECISE-SG100K<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Enroll <strong>100,000+ Singaporean participants<\/strong> across ethnic groups (Chinese, Malay, Indian)<\/li>\n\n\n\n<li>Establish a <strong>longitudinal proteogenomic biobank<\/strong> linked to electronic health records<\/li>\n\n\n\n<li>Identify <strong>proteomic signatures<\/strong> predictive of diabetes, cardiovascular disease, cancer, and neurodegenerative conditions<\/li>\n\n\n\n<li>Enable <strong>precision prevention strategies<\/strong> through dynamic risk stratification<\/li>\n<\/ul>\n\n\n\n<p>Thermo Fisher\u2019s end-to-end proteomics infrastructure provides the scalability and analytical rigor required for population-level studies, positioning the PRECISE-SG100K as one of Asia\u2019s most ambitious precision health programs.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-amp-scientific-implications\">Market &amp; Scientific Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Proteomics Momentum:<\/strong> Reflects growing institutional adoption of proteomics as a complement to genomics in precision medicine<\/li>\n\n\n\n<li><strong>Commercial Validation:<\/strong> Strengthens Thermo Fisher\u2019s leadership in integrated multi-omics solutions amid rising demand from national biobanks<\/li>\n\n\n\n<li><strong>Asian Health Equity:<\/strong> Addresses historical underrepresentation of Asian populations in global proteomic datasets<\/li>\n\n\n\n<li><strong>Platform Synergy:<\/strong> Demonstrates seamless interoperability between Thermo Fisher\u2019s acquired assets (Olink, Seer) and core MS technology<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding collaboration scope, technological performance, and research outcomes. Actual results may vary due to study execution, data interpretation, and regulatory or operational factors.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Thermo Fisher Scientific Inc. (NYSE: TMO), the global life sciences leader, announced a strategic collaboration&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[1261,523],"class_list":["post-62815","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-nyse-tmo","tag-thermo-fisher-scientific"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Thermo Fisher Scientific Partners with Singapore\u2019s PRECISE to Power Landmark Proteomics Study PRECISE-SG100K - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Thermo Fisher Scientific Inc. (NYSE: TMO), the global life sciences leader, announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to accelerate the PRECISE-SG100K population health initiative\u2014a large-scale effort to integrate deep proteomic profiling into precision medicine. The partnership will deploy Thermo Fisher\u2019s integrated proteomics ecosystem, combining the Olink Proximity Extension Assay (PEA) platform, the Orbitrap Astral\u2122 high-resolution mass spectrometry system, and Seer\u2019s Proteograph\u2122 Product Suite to generate real-time biological insights for early disease detection and personalized intervention.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=62815\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thermo Fisher Scientific Partners with Singapore\u2019s PRECISE to Power Landmark Proteomics Study PRECISE-SG100K\" \/>\n<meta property=\"og:description\" content=\"Thermo Fisher Scientific Inc. (NYSE: TMO), the global life sciences leader, announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to accelerate the PRECISE-SG100K population health initiative\u2014a large-scale effort to integrate deep proteomic profiling into precision medicine. The partnership will deploy Thermo Fisher\u2019s integrated proteomics ecosystem, combining the Olink Proximity Extension Assay (PEA) platform, the Orbitrap Astral\u2122 high-resolution mass spectrometry system, and Seer\u2019s Proteograph\u2122 Product Suite to generate real-time biological insights for early disease detection and personalized intervention.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=62815\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-10T15:32:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-10T15:32:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62815#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62815\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Thermo Fisher Scientific Partners with Singapore\u2019s PRECISE to Power Landmark Proteomics Study PRECISE-SG100K\",\"datePublished\":\"2026-04-10T15:32:31+00:00\",\"dateModified\":\"2026-04-10T15:32:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62815\"},\"wordCount\":359,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"NYSE: TMO\",\"Thermo Fisher Scientific\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=62815#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62815\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=62815\",\"name\":\"Thermo Fisher Scientific Partners with Singapore\u2019s PRECISE to Power Landmark Proteomics Study PRECISE-SG100K - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-04-10T15:32:31+00:00\",\"dateModified\":\"2026-04-10T15:32:32+00:00\",\"description\":\"Thermo Fisher Scientific Inc. (NYSE: TMO), the global life sciences leader, announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to accelerate the PRECISE-SG100K population health initiative\u2014a large-scale effort to integrate deep proteomic profiling into precision medicine. The partnership will deploy Thermo Fisher\u2019s integrated proteomics ecosystem, combining the Olink Proximity Extension Assay (PEA) platform, the Orbitrap Astral\u2122 high-resolution mass spectrometry system, and Seer\u2019s Proteograph\u2122 Product Suite to generate real-time biological insights for early disease detection and personalized intervention.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62815#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=62815\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62815#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thermo Fisher Scientific Partners with Singapore\u2019s PRECISE to Power Landmark Proteomics Study PRECISE-SG100K\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Thermo Fisher Scientific Partners with Singapore\u2019s PRECISE to Power Landmark Proteomics Study PRECISE-SG100K - Insight, China&#039;s Pharmaceutical Industry","description":"Thermo Fisher Scientific Inc. (NYSE: TMO), the global life sciences leader, announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to accelerate the PRECISE-SG100K population health initiative\u2014a large-scale effort to integrate deep proteomic profiling into precision medicine. The partnership will deploy Thermo Fisher\u2019s integrated proteomics ecosystem, combining the Olink Proximity Extension Assay (PEA) platform, the Orbitrap Astral\u2122 high-resolution mass spectrometry system, and Seer\u2019s Proteograph\u2122 Product Suite to generate real-time biological insights for early disease detection and personalized intervention.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=62815","og_locale":"en_US","og_type":"article","og_title":"Thermo Fisher Scientific Partners with Singapore\u2019s PRECISE to Power Landmark Proteomics Study PRECISE-SG100K","og_description":"Thermo Fisher Scientific Inc. (NYSE: TMO), the global life sciences leader, announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to accelerate the PRECISE-SG100K population health initiative\u2014a large-scale effort to integrate deep proteomic profiling into precision medicine. The partnership will deploy Thermo Fisher\u2019s integrated proteomics ecosystem, combining the Olink Proximity Extension Assay (PEA) platform, the Orbitrap Astral\u2122 high-resolution mass spectrometry system, and Seer\u2019s Proteograph\u2122 Product Suite to generate real-time biological insights for early disease detection and personalized intervention.","og_url":"https:\/\/flcube.com\/?p=62815","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-04-10T15:32:31+00:00","article_modified_time":"2026-04-10T15:32:32+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=62815#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=62815"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Thermo Fisher Scientific Partners with Singapore\u2019s PRECISE to Power Landmark Proteomics Study PRECISE-SG100K","datePublished":"2026-04-10T15:32:31+00:00","dateModified":"2026-04-10T15:32:32+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=62815"},"wordCount":359,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["NYSE: TMO","Thermo Fisher Scientific"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=62815#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=62815","url":"https:\/\/flcube.com\/?p=62815","name":"Thermo Fisher Scientific Partners with Singapore\u2019s PRECISE to Power Landmark Proteomics Study PRECISE-SG100K - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-04-10T15:32:31+00:00","dateModified":"2026-04-10T15:32:32+00:00","description":"Thermo Fisher Scientific Inc. (NYSE: TMO), the global life sciences leader, announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to accelerate the PRECISE-SG100K population health initiative\u2014a large-scale effort to integrate deep proteomic profiling into precision medicine. The partnership will deploy Thermo Fisher\u2019s integrated proteomics ecosystem, combining the Olink Proximity Extension Assay (PEA) platform, the Orbitrap Astral\u2122 high-resolution mass spectrometry system, and Seer\u2019s Proteograph\u2122 Product Suite to generate real-time biological insights for early disease detection and personalized intervention.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=62815#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=62815"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=62815#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Thermo Fisher Scientific Partners with Singapore\u2019s PRECISE to Power Landmark Proteomics Study PRECISE-SG100K"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=62815"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62815\/revisions"}],"predecessor-version":[{"id":62817,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62815\/revisions\/62817"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=62815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=62815"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=62815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}